.New Delhi, Delhi, India
Chief minister Arvind Kejriwal on Saturday demanded 85 lakh vaccine doses every month for next three months to vaccinate all in Delhi. (Photo credit: Twitter/ @ArvindKejriwal)

  • CM Arvind Kejriwal appealed to the Centre and experts to bring vaccines for children
  • In an online briefing, he demanded 2.6 crore doses to vaccinate all in Delhi
  • Kejriwal added that vaccine doses to vaccinate people for the next 5-6 days were only left with the city

.Washington D.C., DC, USA
At least 50 components and as many as 100 go into the COVID vaccines. (Photo Credit: Representational Image/Pixabay)

  • US plans to open up trade in the raw materials used to make COVID vaccines
  • Commerce Secretary Katherine Tai said that US would work to increase the raw materials needed to produce vaccines
  • Biden's administration had recently taken heat for blocking such exports

John Oliver has been the host of the series 'Last Week Tonight with John Oliver' since 2014. (Photo credit: YouTube/ @LastWeekTonight)

  • Talk show host John Oliver dispelled a lot of myths around COVID-19 vaccines in latest ‘Last Week Tonight’
  • He called out on right-wing personalities like Joe Rogan and Tucker Carlson
  • Oliver said that increasing vaccine hesitancy across the States was disturbing

.New York, NY, USA
Pfizer coronavirus vaccines before being administered to people in Spain. (Photo Credit: PTI)

  • Pfizer is in discussion with the Indian government about its vaccine use in the country
  • In April, the pharma giant offered a not-for-profit price for its vaccine in India
  • Pfizer had earlier said that initially it would supply its vaccine through government contracts only

.New Delhi, Delhi, India
The Delhi government has placed orders for 1.34 crore vaccine doses, which will be delivered over the next three months. (Photo credit: PTI)

  • Around 90 lakh people are eligible for the jabs under 18-45 age category in Delhi
  • Five vaccination booths each have been set up at 77 schools for vaccination
  • Pre-registration is mandatory for vaccination in the 18-45 age group

Vaccination for 18-45 age group started from May 1. (Photo credit: PTI)

  • The Centre has told the Supreme Court that 122 crore doses will be needed to vaccinate the 18-45 age group
  • Centre said vaccination is the topmost priority of the government
  • A total of 59 crore people constitute in the 18-45 age group

Zydus Cadilla got the approval for emergency use of drug Virafin by the Indian government on Saturday. (Photo credit: PTI)

  • Zydus Cadila's Virafin got emergency use approval for moderate COVID-19 cases by the Indian government
  • The production of Virafin is going to start in June, the company aims to produce 240 million doses per year
  • The drug is said to reduce the viral load and helps in avoiding the need of oxygen

India recently approved the Russian vaccine Sputnik V for emergency use across the country. (Photo credit: Unsplash)

  • India is running world's biggest COVID-19 vaccination drive
  • The Indian government is vaccinating its people for free in central government run units
  • A lot of state governments have announced to inoculate people free of cost as well

.Washington D.C., DC, USA
US has administered over 200 million COVID vaccine shots and deaths have fallen dramatically. (Photo credit: AP/ PTI)

  • President Joe Biden has met some buig targets in his first 100 days in office
  • The Biden administration has achieved a lot in improving COVID situation and changing foreign policies
  • However, it is still in attack for its failure to handle immigration at borders and raging gun violence

Sputnik V, Russia's COVID vaccine is said to have 91% efficacy and will be used in India for emergency use. (Photo Credit: Unsplash)

  • Sputnik V, Russia's COVID-19 vaccine was approved by Indian government for emergency use, earlier this month
  • The vaccine will initially be imported, until the production starts in the next quarter
  • Companies that will produce the vaccine, include Hetero Biopharma, Gland Pharma, Stelis Biopharma and Panacea Biotec